1. Department of Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney, Mater Hospital and Royal North Shore Hospital, Sydney, Australia;
2. University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland;
3. The Angeles Clinic and Research Institute, Los Angeles, CA;
4. University of Chicago Medical Center, Chicago, IL;
5. Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile;
6. Hospices Civils De Lyon, Pierre-Bénite, France;
7. Hospital, Richmond, United Kingdom;
8. Westmead and Blacktown Hospitals, Melanoma Institute Australia, and The University of Sydney, Sydney, Australia;
9. Dermatology department, CHRU, AP-HM Hôpital de la Timone , Marseille France, Marseille, France;
10. Seoul National University Hospital, Seoul, Korea, Republic of (South);
11. N. N. Blokhin Russian Cancer Research Center, Moscow, Russia;
12. Gustave Roussy Institute, Paris, France;
13. The Royal Marsden Hospital, London, United Kingdom;
14. Merck & Co., Inc., Kenilworth, NJ;
15. Incyte Corporation, Wilmington, DE;
16. Abramson Cancer Center, Philadelphia, PA;